Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahnum Shahzad

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|April 9, 2025
Participants in the FDA's Biomarker Qualification ProgramMahnum Shahzad, Ariel D Stern
JAMA|January 27, 2023
Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval PathwayMahnum Shahzad, Huseyin Naci, Anita K Wagner
The American Journal of Psychiatry|March 1, 2024
Setting the Record Straight on Long-Term Use, Dose Escalation, and Potential Misuse of Prescription BenzodiazepinesStephen B Soumerai, Mahnum Shahzad, Carl Salzman
JAMA|August 20, 2025
Threats of Weather Disasters for Drug Manufacturing Facilities in the USMahnum Shahzad, Leticia M Nogueira, Anita Wagner
JAMA Pediatrics|December 9, 2024
FDA Approval of Orphan Drug Indications for Pediatric Patients, 2011-2023Apoorva Kakkilaya, Mahnum Shahzad, Florence T Bourgeois
JAMA Internal Medicine|October 18, 2021
Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated ApprovalMahnum Shahzad, Huseyin Naci, Anita K Wagner
Health Affairs (Project Hope)|August 17, 2022
Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory TrialsRichard G Frank, Mahnum Shahzad, Ezekiel J Emanuel
JAMA Health Forum|June 26, 2026
GLP-1 Prescriptions for Weight Loss by Differences in Insurance Plan CoverageMahnum Shahzad, Protima Advani, Oluwayomi Akintola, et al.
Health Economics|January 13, 2022
Biosimilar competition: Early learningRichard G Frank, Mahnum Shahzad, Aaron S Kesselheim, et al.
The American Journal of Managed Care|November 14, 2022
Changes in use of low-value services during the COVID-19 pandemicMahnum Shahzad, Zirui Song, Michael E Chernew, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|April 9, 2025
Participants in the FDA's Biomarker Qualification ProgramMahnum Shahzad, Ariel D Stern
JAMA|January 27, 2023
Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval PathwayMahnum Shahzad, Huseyin Naci, Anita K Wagner
The American Journal of Psychiatry|March 1, 2024
Setting the Record Straight on Long-Term Use, Dose Escalation, and Potential Misuse of Prescription BenzodiazepinesStephen B Soumerai, Mahnum Shahzad, Carl Salzman
JAMA|August 20, 2025
Threats of Weather Disasters for Drug Manufacturing Facilities in the USMahnum Shahzad, Leticia M Nogueira, Anita Wagner
JAMA Pediatrics|December 9, 2024
FDA Approval of Orphan Drug Indications for Pediatric Patients, 2011-2023Apoorva Kakkilaya, Mahnum Shahzad, Florence T Bourgeois
JAMA Internal Medicine|October 18, 2021
Estimated Medicare Spending on Cancer Drug Indications With a Confirmed Lack of Clinical Benefit After US Food and Drug Administration Accelerated ApprovalMahnum Shahzad, Huseyin Naci, Anita K Wagner
Health Affairs (Project Hope)|August 17, 2022
Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory TrialsRichard G Frank, Mahnum Shahzad, Ezekiel J Emanuel
JAMA Health Forum|June 26, 2026
GLP-1 Prescriptions for Weight Loss by Differences in Insurance Plan CoverageMahnum Shahzad, Protima Advani, Oluwayomi Akintola, et al.
Health Economics|January 13, 2022
Biosimilar competition: Early learningRichard G Frank, Mahnum Shahzad, Aaron S Kesselheim, et al.
The American Journal of Managed Care|November 14, 2022
Changes in use of low-value services during the COVID-19 pandemicMahnum Shahzad, Zirui Song, Michael E Chernew, et al.
Pageof 2